Title: An open label 3-arm randomised phase 2 study to compare the safety and efficacy of ponatinib in combination with either chemotherapy or blinatumomab

Funder
Amgen Ltd

Principal Investigator

Co-Investigators
Thomas, Ian

Project Details
Net value award figure for Cardiff University: £1,564,590.00
Start date: 01/01/2019
End date: 31/12/2025

Last updated on 2020-25-10 at 06:01